Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Arnesen

Showing results (11-20 of 218) with videos related to

Pageof 22
Sort By:
Nutrients|October 3, 2020
Very Long Chain Marine <i>n</i>-3 Polyunsaturated Fatty Acids in Atherothrombotic Heart Disease. A Brief Review, with a Focus on Metabolic EffectsHarald Arnesen, Peder L Myhre, Ingebjørg Seljeflot
Metabolism: Clinical and Experimental|February 23, 2013
Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffnessThomas W Weiss, Harald Arnesen, Ingebjorg Seljeflot
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 20, 2021
Omega-3 supplements do not prevent cardiovascular diseasePeder Langeland Myhre, Ingebjørg Seljeflot, Harald Arnesen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 11, 2011
[Don't withdraw all blood platelet inhibitors]Bjørn Bendz, Knut Endresen, Jan Eritsland, et al.
Atherosclerosis|April 12, 2002
Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart diseaseIngebjørg Seljeflot, Serena Tonstad, Ingvar Hjermann, et al.
International Journal of Psychiatry in Medicine|December 17, 2008
Health-related quality of life in non-cardiac chest pain patients with and without panic disorderToril Dammen, Øivind Ekeberg, Harald Arnesen, et al.
Thrombosis Research|May 29, 2002
Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart diseaseIngebjørg Seljeflot, Serena Tonstad, Ingvar Hjermann, et al.
Thrombosis Journal|June 15, 2019
A brief review on resistance to P2Y<sub>12</sub> receptor antagonism in coronary artery diseaseEllen M K Warlo, Harald Arnesen, Ingebjørg Seljeflot
Thrombosis Research|February 15, 2003
Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery diseaseKjell Andersen, Mette Hurlen, Harald Arnesen, et al.
Thrombosis Research|December 31, 2003
Soluble tissue factor as predictor of future events in patients with acute myocardial infarctionIngebjørg Seljeflot, Mette Hurlen, Torstein Hole, et al.
Pageof 22

Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
Nutrients|October 3, 2020
Very Long Chain Marine <i>n</i>-3 Polyunsaturated Fatty Acids in Atherothrombotic Heart Disease. A Brief Review, with a Focus on Metabolic EffectsHarald Arnesen, Peder L Myhre, Ingebjørg Seljeflot
Metabolism: Clinical and Experimental|February 23, 2013
Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffnessThomas W Weiss, Harald Arnesen, Ingebjorg Seljeflot
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 20, 2021
Omega-3 supplements do not prevent cardiovascular diseasePeder Langeland Myhre, Ingebjørg Seljeflot, Harald Arnesen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 11, 2011
[Don't withdraw all blood platelet inhibitors]Bjørn Bendz, Knut Endresen, Jan Eritsland, et al.
Atherosclerosis|April 12, 2002
Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart diseaseIngebjørg Seljeflot, Serena Tonstad, Ingvar Hjermann, et al.
International Journal of Psychiatry in Medicine|December 17, 2008
Health-related quality of life in non-cardiac chest pain patients with and without panic disorderToril Dammen, Øivind Ekeberg, Harald Arnesen, et al.
Thrombosis Research|May 29, 2002
Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart diseaseIngebjørg Seljeflot, Serena Tonstad, Ingvar Hjermann, et al.
Thrombosis Journal|June 15, 2019
A brief review on resistance to P2Y<sub>12</sub> receptor antagonism in coronary artery diseaseEllen M K Warlo, Harald Arnesen, Ingebjørg Seljeflot
Thrombosis Research|February 15, 2003
Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery diseaseKjell Andersen, Mette Hurlen, Harald Arnesen, et al.
Thrombosis Research|December 31, 2003
Soluble tissue factor as predictor of future events in patients with acute myocardial infarctionIngebjørg Seljeflot, Mette Hurlen, Torstein Hole, et al.
Pageof 22